Finepoint Capital LP
CIK 1608126 · Holdings on Dec 31, 2024 · First reported Feb 13, 2025
Top ten holdings
Q4 2024- QXO45.73%
- 53030730517.38%
- LLYVK6.38%
- ARGX3.75%
- RVMD3.58%
- SWTX3.12%
- ASND2.94%
- MLTX2.80%
- SRPT2.27%
- LKFT2.14%
Share classes counted separately90.09%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- QXOWeight decreased · -3.65 pp49.38% → 45.73%Shares -816.96K (-3.17%)
- 530307305Weight decreased · -1.37 pp18.75% → 17.38%Shares +21.20K (+1.06%)
- SWTXWeight increased · +0.58 pp2.54% → 3.12%Shares +97.90K (+15.04%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 24
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | QXOQXO INCCOM NEW View history and evidence | $396.45M | 45.73% | 24.93M shares | 49.38% → 45.73%-3.65 pp -816.96K (-3.17%) | Reduced | ↗▾ |
| 02 | 530307305LIBERTY BROADBAND-CCOM SER C View history and evidence | $150.69M | 17.38% | 2.02M shares | 18.75% → 17.38%-1.37 pp +21.20K (+1.06%) | Added | ↗▾ |
| 03 | LLYVKLIBERTY MEDIA CORP-LIBERTY-CCOM LBTY LIV S C View history and evidence | $55.32M | 6.38% | 812.79K shares | Prior unavailable +812.79K | New | ↗▾ |
| 04 | ARGXARGENX SE - ADRSPONSORED ADR View history and evidence | $32.55M | 3.75% | 52.93K shares | 3.59% → 3.75%+0.16 pp -1.50K (-2.76%) | Reduced | ↗▾ |
| 05 | RVMDREVOLUTION MEDICINES INC View history and evidence | $31.07M | 3.58% | 710.26K shares | 4.04% → 3.58%-0.46 pp -21.70K (-2.96%) | Reduced | ↗▾ |
| 06 | SWTXSPRINGWORKS THERAPEUTICS INC View history and evidence | $27.05M | 3.12% | 748.75K shares | 2.54% → 3.12%+0.58 pp +97.90K (+15.04%) | Added | ↗▾ |
| 07 | ASNDASCENDIS PHARMA A/SSPONSORED ADR View history and evidence | $25.45M | 2.94% | 184.87K shares | 3.45% → 2.94%-0.51 pp -5.20K (-2.74%) | Reduced | ↗▾ |
| 08 | MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD View history and evidence | $24.26M | 2.80% | 447.94K shares | 2.38% → 2.80%+0.42 pp +59.10K (+15.20%) | Added | ↗▾ |
| 09 | SRPTSAREPTA THERAPEUTICS INC View history and evidence | $19.69M | 2.27% | 161.94K shares | 2.03% → 2.27%+0.24 pp +28.40K (+21.27%) | Added | ↗▾ |
| 10 | LKFTLAKEFRONT BIOTHERAPEUTIC-ADRSPON ADR View history and evidence | $18.56M | 2.14% | 674.76K shares | 1.95% → 2.14%+0.19 pp +117.00K (+20.98%) | Added | ↗▾ |
Options overlay 2
$770.62M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
SPYSS SPDR S&P 500 ETF TRUST-USTR UNIT View history and evidence | Put | 755.00K | $442.49M | +200.00K (+36.04%) | ▾ |
IWMISHARES RUSSELL 2000 ETFRUSSELL 2000 ETF View history and evidence | Put | 1.49M | $328.13M | +420.00K (+39.44%) | ▾ |
2 / 2 options · preview only
Exited positions 5
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| TVTX TRAVERE THERAPEUTICS INC | Non-derivative | -1,782,267 | -$24.93M | SEC filing ↗ | SEC filing ↗ |
| ACAD ACADIA PHARMACEUTICALS INC | Non-derivative | -905,384 | -$13.92M | SEC filing ↗ | SEC filing ↗ |
| IVCPW SWIFTMERGE ACQUISITION -CW23 | Non-derivative | -490,000 | -$39.20K | SEC filing ↗ | SEC filing ↗ |
3 / 5 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1608126 · Period 2024-12-31
Data loaded 2026-09-23 · First reported 2025-02-13
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1637498342
}Take these holdings further.
This page includes 26 of 26 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 26 of 26 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1608126","quarter":"2024Q4","page_size":100}
get_institutional_manager_history
{"cik":"1608126","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.